NAUT - צמיחת הכנסות שנתית ב-12 החודשים האחרונים nautilus.bio

The prospects for Nautilus Biotechnology (NAUT) rely on the adoption rate of proteomics in science. However, export restrictions and component supply chain challenges are hindering global development. Meanwhile, expanding demand from pharmaceutical laboratories creates growth potential. This chart of year-over-year sales volume changes for LTM is available in the GURU.Markets system, where 0.00 determines this parameter level.
Nautilus Biotechnology (NAUT) - פילוחי מדדים ודוחות פיננסיים

Scaling the delivery of precision protein analysis equipment requires flawless logistics and electronics protection for Nautilus Biotechnology (NAUT). This metric compares trailing twelve-month (TTM) revenue with the same period last year, eliminating seasonality and data gaps. By analyzing the annual revenue growth trend over the TTM period, an investor can discern the business's actual expansion rate. However, a sharp spike in the curve may signal declining profitability, serving as a critical marker for assessing the asset's sustainability.